Common Contracts
3 similar Stock Option Agreement contracts by Impax Laboratories Inc
IMPAX LABORATORIES, INC. STOCK OPTION AGREEMENTStock Option Agreement • August 9th, 2017 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
Pursuant to your grant notice (the “Grant Notice”) and this Stock Option Agreement (the “Agreement”), Impax Laboratories, Inc. (the “Company”) has granted you (the “Optionee”) a nontransferable option under the Company’s Fourth Amended and Restated 2002 Equity Incentive Plan, as the same may from time to time be amended (the “Plan”), to purchase the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), indicated in the Grant Notice (collectively, the “Option”).
STOCK OPTION AGREEMENTStock Option Agreement • May 10th, 2017 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
As an inducement material to the decision by you (the “Optionee”) to accept employment with Impax Laboratories, Inc. (the “Company”) and pursuant to your grant notice (the “Grant Notice”), this Stock Option Agreement (the “Agreement”) and that certain Employment Agreement entered into between you and the Company effective as of March 24, 2017 (the “Employment Agreement”), the Company has granted you (the “Optionee”) a nontransferable option to purchase the number of shares (the “Shares”) of the Company’s common stock, par value $0.01 per share (the “Common Stock”), indicated in the Grant Notice (collectively, the “Option”). This Option is made and granted as a stand-alone award and is not granted under or pursuant to the Company’s Third Amended and Restated 2002 Equity Incentive Plan (the “Plan”). However, unless otherwise defined herein, capitalized terms in this Agreement shall have the meaning ascribed in the Plan.
IMPAX LABORATORIES, INC. STOCK OPTION AGREEMENTStock Option Agreement • June 14th, 2013 • Impax Laboratories Inc • Pharmaceutical preparations • Delaware
Pursuant to your grant notice (the "Grant Notice") and this Stock Option Agreement (the "Agreement"), Impax Laboratories, Inc. (the "Company") has granted you (the "Optionee") a nontransferable option under the Company's Second Amended and Restated 2002 Equity Incentive Plan, as the same may from time to time be amended (the "Plan"), to purchase the number of shares (the "Shares") of the Company's common stock, par value $0.01 per share (the "Common Stock"), indicated in the Grant Notice (collectively, the "Option").
